Beijing SL Pharmaceutical Co., Ltd. (SHE:002038)
China
· Delayed Price · Currency is CNY 6.75
-0.08 (-1.17%)
Apr 29, 2026, 3:04 PM CST
Beijing SL Pharmaceutical Revenue
In the year 2025, Beijing SL Pharmaceutical had annual revenue of 623.64M CNY, down -5.57%. Beijing SL Pharmaceutical had revenue of 164.89M in the quarter ending December 31, 2025, with 37.57% growth.
Revenue
623.64M
Revenue Growth
-5.57%
P/S Ratio
11.12
Revenue / Employee
701.51K
Employees
889
Market Cap
6.93B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 623.64M | -36.78M | -5.57% |
| Dec 31, 2024 | 660.42M | -357.94M | -35.15% |
| Dec 31, 2023 | 1.02B | -31.81M | -3.03% |
| Jan 1, 2023 | 1.05B | -164.65M | -13.55% |
| Jan 1, 2022 | 1.21B | 102.08M | 9.17% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Jan 1, 2019 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Zhejiang AngLiKang Pharmaceutical CO.,LTD. | 1.45B |
| Northeast Pharmaceutical Group | 7.07B |
| Zhejiang Garden Biopharmaceutical | 1.19B |
| Cisen Pharmaceutical | 3.44B |
| Guizhou Bailing Group Pharmaceutical | 3.05B |
| Jiangsu Yahong Meditech | 277.12M |
| Tianjin Tianyao Pharmaceuticals | 2.73B |
| Zhejiang Tianyu Pharmaceutical | 3.11B |